{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:54:18Z","timestamp":1770972858891,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Program for Research Groups of Excellence of the Seneca Foundation","award":["19894\/GERM\/15"],"award-info":[{"award-number":["19894\/GERM\/15"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.vetimm.2018.03.003","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T13:21:22Z","timestamp":1520515282000},"page":"65-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Changes in serum anti- Leishmania  antibody concentrations measured by time-resolved immunofluorometric assays in dogs with leishmaniosis after treatment"],"prefix":"10.1016","volume":"198","author":[{"given":"Ana","family":"Cantos-Barreda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dami\u00e1n","family":"Escribano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Mart\u00ednez-Subiela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Pardo-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6680-4146","authenticated-orcid":false,"given":"Sergi","family":"Segarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 J.","family":"Cer\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2018.03.003_bib0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrd984","article-title":"Therapeutic antibodies for human diseases at the dawn of the twenty-first century","volume":"2","author":"Brekke","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.vetimm.2018.03.003_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vetimm.2017.05.007","article-title":"New wide dynamic range assays for quantification of anti-Leishmania IgG2 and IgA antibodies in canine serum","volume":"189","author":"Cantos-Barreda","year":"2017","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2018.03.003_bib0015","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/vr.136.20.514","article-title":"Serological diagnosis and treatment of canine leishmaniasis","volume":"136","author":"Ferrer","year":"1995","journal-title":"Vet. Rec."},{"key":"10.1016\/j.vetimm.2018.03.003_bib0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.rvsc.2015.01.002","article-title":"Urinary ferritin and cystatin C concentrations at different stages of kidney disease in leishmaniotic dogs","volume":"99","author":"Garc\u00eda-Mart\u00ednez","year":"2015","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.vetimm.2018.03.003_bib0025","first-page":"69","article-title":"Canine leishmaniosis \u2013 an emerging disease","volume":"61","author":"Kaszak","year":"2015","journal-title":"Ann. Parasitol."},{"key":"10.1016\/j.vetimm.2018.03.003_bib0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00034983.1998.11813276","article-title":"Comparative efficacy of meglumine antimoniate and aminosidine sulphate alone or in combination, in canine leishmaniasis","volume":"92","author":"Oliva","year":"1998","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.vetimm.2018.03.003_bib0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1939-1676.2006.tb02887.x","article-title":"Dynamics of Leishmania-specific immunoglobulin isotypes in dogs with clinical leishmaniasis before and after treatment","volume":"20","author":"Rodr\u00edguez","year":"2006","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.vetimm.2018.03.003_bib0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.vetpar.2011.11.016","article-title":"One-year clinical and parasitological follow-up of dogs treated with marbofloxacin for canine leishmaniosis","volume":"186","author":"Rougier","year":"2012","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetimm.2018.03.003_bib0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.vetpar.2017.04.014","article-title":"Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis","volume":"239","author":"Segarra","year":"2017","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetimm.2018.03.003_bib0050","series-title":"The Nonhuman Primate in the Nonclinical Drug Development and Safety Assessment","first-page":"716","author":"Shenton","year":"2015"},{"key":"10.1016\/j.vetimm.2018.03.003_bib0055","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1939-165X.2012.00467.x","article-title":"Serum cardiac troponin I concentrations in dogs with leishmaniasis: correlation with age and clinicopathologic abnormalities","volume":"4","author":"Silvestrini","year":"2012","journal-title":"Vet. Clin. Pathol."},{"key":"10.1016\/j.vetimm.2018.03.003_bib0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-4017(00)00446-5","article-title":"Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas: evolution in the course of infection and after treatment","volume":"96","author":"Solano-Gallego","year":"2001","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetimm.2018.03.003_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2009.05.022","article-title":"Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis","volume":"165","author":"Solano-Gallego","year":"2009","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetimm.2018.03.003_bib0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1756-3305-4-86","article-title":"LeishVet guidelines for the practical management of canine leishmaniosis","volume":"4","author":"Solano-Gallego","year":"2011","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.vetimm.2018.03.003_bib0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13071-016-1519-0","article-title":"Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease","volume":"9","author":"Solano-Gallego","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.vetimm.2018.03.003_bib0080","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tvjl.2010.05.025","article-title":"Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol","volume":"188","author":"Torres","year":"2011","journal-title":"Vet. J."},{"issue":"9","key":"10.1016\/j.vetimm.2018.03.003_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0005910","article-title":"Induction of allopurinol resistance in Leishmania infantum isolated from dogs","volume":"11","author":"Yasur-Landau","year":"2017","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242717305111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242717305111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T03:46:35Z","timestamp":1530071195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242717305111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":17,"alternative-id":["S0165242717305111"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2018.03.003","relation":{},"ISSN":["0165-2427"],"issn-type":[{"value":"0165-2427","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in serum anti-Leishmania antibody concentrations measured by time-resolved immunofluorometric assays in dogs with leishmaniosis after treatment","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2018.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}